iBio, Inc.
IBIO
$0.818
$0.0253.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.36% | 29.25% | 56.01% | 61.69% | 69.54% |
| Total Depreciation and Amortization | -33.44% | -2.63% | 2.26% | 15.73% | 30.00% |
| Total Amortization of Deferred Charges | -100.00% | -100.00% | -89.73% | -50.41% | 1.00% |
| Total Other Non-Cash Items | 45.46% | -9.34% | -65.06% | -70.25% | -87.02% |
| Change in Net Operating Assets | -211.29% | -314.90% | -141.78% | -153.98% | -112.44% |
| Cash from Operations | 33.38% | 14.80% | 22.40% | 39.04% | 49.50% |
| Capital Expenditure | 58.30% | 30.82% | 93.56% | 96.73% | 94.59% |
| Sale of Property, Plant, and Equipment | -88.00% | -97.51% | -97.51% | -95.54% | -73.81% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.80% | -71.18% | -77.58% | -90.77% | -93.22% |
| Cash from Investing | -45.69% | -81.09% | -77.68% | -87.07% | -86.07% |
| Total Debt Issued | -100.00% | -- | 79.00% | 79.00% | 79.00% |
| Total Debt Repaid | 6.80% | 56.02% | 83.66% | 78.88% | 80.66% |
| Issuance of Common Stock | -5.25% | 26.90% | 69.55% | 123.21% | 91.62% |
| Repurchase of Common Stock | 100.00% | 100.00% | 82.05% | 82.05% | 82.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 95.45% | 95.45% | 100.00% |
| Cash from Financing | -10.98% | 65.74% | 501.87% | 964.49% | 3,271.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.08% | 2,763.06% | 158.44% | 132.46% | 88.80% |